BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 27012205)

  • 1. Che-1 gene silencing induces osteosarcoma cell apoptosis by inhibiting mutant p53 expression.
    Liu M; Wang D; Li N
    Biochem Biophys Res Commun; 2016 Apr; 473(1):168-173. PubMed ID: 27012205
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Che-1 modulates the decision between cell cycle arrest and apoptosis by its binding to p53.
    Desantis A; Bruno T; Catena V; De Nicola F; Goeman F; Iezzi S; Sorino C; Gentileschi MP; Germoni S; Monteleone V; Pellegrino M; Kann M; De Meo PD; Pallocca M; Höpker K; Moretti F; Mattei E; Reinhardt HC; Floridi A; Passananti C; Benzing T; Blandino G; Fanciulli M
    Cell Death Dis; 2015 May; 6(5):e1764. PubMed ID: 25996291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Che-1 promotes tumor cell survival by sustaining mutant p53 transcription and inhibiting DNA damage response activation.
    Bruno T; Desantis A; Bossi G; Di Agostino S; Sorino C; De Nicola F; Iezzi S; Franchitto A; Benassi B; Galanti S; La Rosa F; Floridi A; Bellacosa A; Passananti C; Blandino G; Fanciulli M
    Cancer Cell; 2010 Aug; 18(2):122-34. PubMed ID: 20708154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Estrogen receptor alpha inhibits p53-mediated transcriptional repression: implications for the regulation of apoptosis.
    Sayeed A; Konduri SD; Liu W; Bansal S; Li F; Das GM
    Cancer Res; 2007 Aug; 67(16):7746-55. PubMed ID: 17699779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RASSF5 inhibits growth and invasion and induces apoptosis in osteosarcoma cells through activation of MST1/LATS1 signaling.
    Zhou XH; Yang CQ; Zhang CL; Gao Y; Yuan HB; Wang C
    Oncol Rep; 2014 Oct; 32(4):1505-12. PubMed ID: 25109282
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aplasia Ras homologue member Ⅰ overexpression inhibits tumor growth and induces apoptosis through inhibition of PI3K/Akt survival pathways in human osteosarcoma MG-63 cells in culture.
    Ye K; Wang S; Yang Y; Kang X; Wang J; Han H
    Int J Mol Med; 2015 Sep; 36(3):776-82. PubMed ID: 26165148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of Estrogen Receptor Alpha Inhibits Cell Proliferation, Differentiation and Enhances the Chemosensitivity of P53-Positive U2OS Osteosarcoma Cell.
    Wang JY; Chen CM; Chen CF; Wu PK; Chen WM
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of GRIM-19 accelerates radiation-induced osteosarcoma cells apoptosis by p53 stabilization.
    Chen W; Liu Q; Fu B; Liu K; Jiang W
    Life Sci; 2018 Sep; 208():232-238. PubMed ID: 30005830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of PTHrP-cAMP-CREB1 signaling following p53 loss is essential for osteosarcoma initiation and maintenance.
    Walia MK; Ho PM; Taylor S; Ng AJ; Gupte A; Chalk AM; Zannettino AC; Martin TJ; Walkley CR
    Elife; 2016 Apr; 5():. PubMed ID: 27070462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutant p53 induces the GEF-H1 oncogene, a guanine nucleotide exchange factor-H1 for RhoA, resulting in accelerated cell proliferation in tumor cells.
    Mizuarai S; Yamanaka K; Kotani H
    Cancer Res; 2006 Jun; 66(12):6319-26. PubMed ID: 16778209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
    Novello C; Pazzaglia L; Conti A; Quattrini I; Pollino S; Perego P; Picci P; Benassi MS
    PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Che-1: a new effector of checkpoints signaling.
    Floridi A; Fanciulli M
    Cell Cycle; 2007 Apr; 6(7):804-6. PubMed ID: 17377493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inorganic phosphate enhances sensitivity of human osteosarcoma U2OS cells to doxorubicin via a p53-dependent pathway.
    Spina A; Sorvillo L; Di Maiolo F; Esposito A; D'Auria R; Di Gesto D; Chiosi E; Naviglio S
    J Cell Physiol; 2013 Jan; 228(1):198-206. PubMed ID: 22674530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutant p53 gain of function can be at the root of dedifferentiation of human osteosarcoma MG63 cells into 3AB-OS cancer stem cells.
    Di Fiore R; Marcatti M; Drago-Ferrante R; D'Anneo A; Giuliano M; Carlisi D; De Blasio A; Querques F; Pastore L; Tesoriere G; Vento R
    Bone; 2014 Mar; 60():198-212. PubMed ID: 24373920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferonalpha enhances etoposide-induced apoptosis in human osteosarcoma U2OS cells by a p53-dependent pathway.
    Yuan XW; Zhu XF; Liang SG; Fan Q; Chen ZX; Huang XF; Sheng PY; He AS; Yang ZB; Deng R; Feng GK; Liao WM
    Life Sci; 2008 Feb; 82(7-8):393-401. PubMed ID: 18191951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. eEF1Bγ binds the Che-1 and TP53 gene promoters and their transcripts.
    Pisani C; Onori A; Gabanella F; Delle Monache F; Borreca A; Ammassari-Teule M; Fanciulli M; Di Certo MG; Passananti C; Corbi N
    J Exp Clin Cancer Res; 2016 Sep; 35(1):146. PubMed ID: 27639846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Programmed cell death 2 functions as a tumor suppressor in osteosarcoma.
    Yang Y; Jin Y; Du W
    Int J Clin Exp Pathol; 2015; 8(9):10894-900. PubMed ID: 26617804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of miR-663b inhibits cell proliferation and induces apoptosis in osteosarcoma via regulating TP73 expression.
    Shu Y; Ye W; Gu YL; Sun P
    Bratisl Lek Listy; 2018; 119(1):41-46. PubMed ID: 29405730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HOXA5 overexpression promotes osteosarcoma cell apoptosis through the p53 and p38α MAPK pathway.
    Chen YQ; Yang TQ; Zhou B; Yang MX; Feng HJ; Wang YL
    Gene; 2019 Mar; 689():18-23. PubMed ID: 30521886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Knockdown of TNFAIP1 inhibits growth and induces apoptosis in osteosarcoma cells through inhibition of the nuclear factor-κB pathway.
    Zhang CL; Wang C; Yan WJ; Gao R; Li YH; Zhou XH
    Oncol Rep; 2014 Sep; 32(3):1149-55. PubMed ID: 24969828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.